APS.TO - Aptose Biosciences Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
15,766
18,733
6,274
7,679
4,507
Selling General and Administrative
9,426
10,321
5,502
6,128
7,046
Total Operating Expenses
25,298
29,107
11,826
13,887
11,601
Operating Income or Loss
-25,298
-29,107
-11,826
-13,887
-11,601
Interest Expense
-
-
0
49
31
Total Other Income/Expenses Net
-23
-44
97
-49
886
Income Before Tax
-24,829
-28,868
-11,661
-13,858
-10,540
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-24,829
-28,868
-11,661
-13,858
-10,540
Net Income
-24,829
-28,868
-11,661
-13,858
-10,540
Net Income available to common shareholders
-24,829
-28,868
-11,661
-13,858
-10,540
Reported EPS
Basic
-
-0.86
-0.52
-1.09
-0.89
Diluted
-
-0.86
-0.52
-1.09
-0.89
Weighted average shares outstanding
Basic
-
33,391
22,313
12,743
11,906
Diluted
-
33,391
22,313
12,743
11,906
EBITDA
-
-29,020
-11,577
-13,773
-10,461